[ Tips ] 一分鐘使用導覽
商品編號： F1804A 出版日期： 2018/07/01 作者姓名： Harvard Business Review 商品類別： Marketing 商品規格： 4p 再版日期： 地域： 產業： Pharmaceuticals 個案年度： -
商品敘述：
What''s the optimal number of new products to launch in a given time frame? Does it matter whether the launches are spread out or bunched together, and whether a new product is similar to the rest of a company''s portfolio? To answer those questions, researchers studied 1,904 new drugs launched by U.S. pharmaceutical firms from 1991 to 2015. This article describes their findings, including the calculation that the average firm in the study could increase its market value by more than $700 million if it reduced the irregularity of its launches by 10%. Also included is a Q&A with Ellen Donahue-Dalton, executive vice president and chief marketing and customer experience officer at Medecision, about how that company has put the research findings into practice.
涵蓋領域：
New product marketing;Product introduction;Product portfolio management
相關資料：
哪些人也有訂購？